Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Oragenics, Inc.

TRADE

AMEX: OGENHealthcare / Biotechnology / USA
1.14+0.03+2.70%Vol 2 347 1631Y Perf -72.24%
Oct 16th, 2018 16:00
BID1.12 ASK1.13
Open1.15 Previous Close1.11
Pre-Market1.20 After-Trading1.14
 0.09 8.11%  - -%
Target Price
5.00 
Analyst Rating
— 0.00
Potencial %
338.60 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★+     54.05
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)13 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
17.59 
Earnings Date
30th Oct 2018

Today's Price Range

1.101.20

 

52wk Range

0.384.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
185.00%
3 Months
67.65%
6 Months
-32.14%
1 Year
-72.24%
3 Years
-17.99%
5 Years
-61.87%

Quotes

Name / TickerPriceChg.Chg.%
OGEN1.140.03002.70
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.50
Current Ratio 3.30
Long Term Debt to Total Capital 0.83
Total Debt to Equity 12.01
Interest Coverage -48.80
Leverage Ratio -3.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1 180.81
PS Ratios -97.70
Price to Cash Flow -
Price to Free Cash Flow -7.30
Cash Flow Per Share -1.22
Price to Tangible Book-14.88
Book Value per Share-0.08
Enterprise Value (in ths.)38 628
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-128.60
ROE last 12 Months 653.70
Return on Assets (5Y Avg) -186.82
ROA last 12 Months -160.34
Return on Capital (5Y Avg) -184.78
ROC last 12 Months -38.23
Return on invested Capital Q -38.23
Return on invested Capital Y-418.39
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -32.94
Revenue Growth 5 Years -22.90
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.41-0.387.32
Q02 2017--0.20-
Q01 2017--0.40-
Q03 2016-0.04-0.040.00
Q02 2016--0.05-
Q01 2016--0.05-
Q04 2015--0.06-
Q03 2015--0.05-
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2238.89Positive
12/2018 QR-0.2328.13Positive
12/2018 FY-0.9430.88Positive
12/2019 FY-0.7321.51Positive
Next Report Date30th Oct 2018
Estimated EPS Next Report-0.22
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume2 347 163
Shares Outstanding (in ths.)11 840
Trades Count2 574
Dollar Volume2 333 396
Avg. Volume2 463 384
Avg. Weekly Volume10 193 243
Avg. Monthly Volume20 028 656
Avg. Quarterly Volume6 596 966

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

31%69%

Bearish Bullish

54%46%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x